Related Experiment Video
Updated: Jul 17, 2026

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
Published on: October 14, 2022
Spontaneous bacterial peritonitis causing Serratia marcescens and Proteus mirabilis ventriculoperitoneal shunt
Luis M Tumialán1, Franklin Lin, Sanjay K Gupta
1Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia 30322, USA. ltumial@emory.edu
Abstract:
The authors report their experience treating a polymicrobial ventriculoperitoneal (VP) shunt infection in a developmentally delayed 21-year-old woman. Cerebrospinal fluid (CSF) cultures grew Serratia marcescens and Proteus mirabilis. On admission and throughout her hospitalization, results of physical examination of her abdomen were normal, and radiographic studies showed no evidence of bowel perforation or pseudocyst formation. Contrast-enhanced computed tomography of the abdomen revealed a small fluid collection. After a course of intravenous gentamicin and imipenem with cilastatin in conjunction with intrathecal gentamicin, the infection was resolved and the VP shunt was reimplanted. Although VP shunt infections are not uncommon, S. marcescens as a causative agent is exceedingly rare and potentially devastating. Only two previous cases of S. marcescens shunt infection have been reported in the literature. Authors reporting on S. marcescens infections in the central nervous system (CNS) have observed significant morbidity and death. Although more common, the presence of P. mirabilis in the CSF is still rare and highly suggestive of bowel perforation, which was absent in this patient. Spontaneous bacterial peritonitis was the likely source from which these bacteria gained entrance into the VP shunt system, eventually causing ventriculitis in this patient. The authors conclude that in light of the high morbidity associated with S. marcescens infection of the CNS, intrathecal administration of gentamicin should be strongly considered as part of first-line therapy for S. marcescens infections in VP shunts.
Insights
This study details treating a rare polymicrobial ventriculoperitoneal shunt infection caused by Serratia marcescens and Proteus mirabilis. Intrathecal gentamicin was crucial for resolving the infection, highlighting its importance in first-line therapy.
Area of Science:
- Neuroscience
- Infectious Diseases
- Medical Case Study
Background:
- Ventriculoperitoneal (VP) shunts are common in treating hydrocephalus.
- VP shunt infections can lead to significant morbidity and mortality.
- Polymicrobial infections, especially with rare organisms, pose treatment challenges.
Observation:
- A 21-year-old woman with developmental delay presented with a polymicrobial VP shunt infection.
- Cerebrospinal fluid (CSF) cultures identified Serratia marcescens and Proteus mirabilis.
- Abdominal examination and imaging ruled out bowel perforation or pseudocyst formation.
Findings:
- The patient received intravenous gentamicin and imipenem/cilastatin, plus intrathecal gentamicin.
- The infection resolved, and the VP shunt was successfully reimplanted.
- Serratia marcescens is a rare and devastating cause of CNS infections, with only two prior reported cases.
Implications:
- Intrathecal gentamicin should be strongly considered for S. marcescens VP shunt infections.
- The findings suggest spontaneous bacterial peritonitis as a potential source of infection.
- This case underscores the need for aggressive and targeted therapy in rare CNS infections.
